T. Alaviuhkola et al.
water bath for 6 h. 11B NMR (200 MHz, CD3CN): d = À3.06 ppm; 1H
borate), 9.2 ppm (s, 7H; tropylium); ESI-MS: m/z: 806 [2·(8)+ÀB(-Ph-
Ph)4]; exact mass: 805.3981 [M+2·8]+ (calcd for C62H50B, 805.4006).
NMR (200 MHz, CD3CN): d
=
6.6–7.3 ppm (m, arom.); 13C NMR
(500 MHz, CD3CN): d = 116.7 (arom., 2C), 119.6 (arom., 1C), 130.6
(arom., 2C), 159.6 ppm (arom., 1C); ESI-MS: m/z: 429 [ÀB(-O-
Ph)4+2Na+]; exact mass: 429.1245 [M+2Na]+ (calcd for C24H20O4BNa2,
429.1250).
Imidazolium tetrakis(biphenyl)borate (9·2): The complex was prepared
by mixing equimolar amounts of solutions of imidazolium perchlorate (9)
and borate 2 in ethanol (no precipitate). X-ray quality crystals were
grown from ethanol by slow evaporation. 1H NMR (200 MHz, CD3CN):
d = 7.2–7.7 (m, 36H; borate + 2H; imidazolium), 8.5 ppm (s, 1H; imi-
dazolium); ESI-MS: m/z: 761 [2·(9)+ÀB(-Ph-Ph)4]; exact mass: 761.3792
[M+2·9]+ (calcd for C54H46N4B, 761.3816).
Synthesis of the complexes
N-Methylpyridinium tetrakis(4-phenoxyphenyl)borate (6·1): The cation
was prepared according to the literature procedure.[16] The complex was
prepared by mixing equimolar amounts of solutions of N-methylpyridini-
um iodide (6) and borate 1 in acetonitrile (no precipitate). X-ray quality
crystals were grown from acetonitrile by slow evaporation. 1H NMR
(200 MHz, CD3CN + TMS): d = 4.3 (s, 3H; N-CH3), 6.7–7.2 (m, 36H;
borate), 8.0 (m, 2H; Me-pyridinium), 8.5 (t, 1H; Me-pyridinium),
8.6 ppm (d, 2H; Me-pyridinium); ESI-MS: m/z: 876 [2·(6)+ÀB(-Ph-O-
Ph)4]; exact mass: 875.4012 [M+2·6]+ (calcd. for C60H52O4N2B, 875.4020).
1-Methylimidazolium tetrakis(biphenyl)borate (10·2): The complex was
prepared by mixing equimolar amounts of solutions of 1-methylimidazoli-
um perchlorate (10) and borate 2 in acetonitrile (no precipitate). 1H
NMR (200 MHz, CD3CN): d = 3.6 (s, 3H; N-CH3), 7.2–7.6 (m, 36H;
borate + 2H; 1-Me-imidazolium), 8.2 (s, 1H; 1-Me-imidazolium); ESI-
MS: m/z: 790 [2·(10)+ÀB(-Ph-Ph)4]; exact mass: 789.4108 [M+2·10]+
(calcd for C56H50N4B, 789.4129).
1-Ethyl-4-(methoxycarbonyl)pyridinium tetrakis(4-phenoxyphenyl)borate
(7·1): The complex was prepared by mixing equimolar amounts of solu-
tions of 7 and borate 1 in methanol. The solid complex formed immedi-
ately upon mixing of the solutions. X-ray quality crystals were grown
from a solution in acetonitrile by slow evaporation. 1H NMR (200 MHz,
CD3CN): d = 1.6 (t, 3H; N-CH2CH3), 4.0 (s, 3H; OCH3), 4.6 (q, 2H; N-
CH2CH3), 6.8–7.4 (m, 36H; borate), 8.4 (m, 2H; arom. cation), 8.8 ppm
(d, 2H; arom. cation); ESI-MS: m/z: 1020 [2·(7)+ÀB(-Ph-O-Ph)4]; exact
mass: 1019.4431 [M+2·7]+ (calcd for C66H60O8N2B, 1019.4443).
Ion-selective electrodes: Plasticized polymer membrane-based ion-selec-
tive electrodes (ISEs) were prepared by using poly(3,4-ethylenedioxy-
thiophene) (PEDOT) as a solid contact material.[12] PEDOT was deposit-
ed on a glassy carbon (GC) disk electrode (area = 0.07 cm2) by galvano-
static electrochemical polymerization (current
= 0.014 mA, time =
714 s) from a deaerated aqueous solution containing 0.01m 3,4-ethylene-
dioxythiophene and 0.1m sodium poly(sodium 4-styrenesulfonate). The
electropolymerization was performed by using an Autolab General Pur-
pose Electrochemical System (Eco Chemie B.V., The Netherlands) con-
nected to a conventional one-compartment, three-electrode electrochem-
ical cell. The GC disk electrode was used as the working electrode, a GC
rod as an auxiliary electrode, and an Ag/AgCl (3m KCl) electrode as the
reference electrode. Prior to electropolymerization, the GC disk elec-
trode was polished with 0.3 mm alumina, rinsed with deionized water, and
cleaned ultrasonically. After electropolymerization, the GC/PEDOT elec-
trodes were rinsed with deionized water and conditioned for at least 24 h
in 0.01m N-methylpyridinium iodide solution. The GC/PEDOT electro-
des were then coated with ion-selective membranes of the following com-
position (w/w): tetraarylborate (1.6–2.2%), PVC (32–33%), and o-NPOE
(65–66%). The components of the membrane were dissolved in THF and
applied by means of a micropipette onto the GC/PEDOT electrode.
After evaporation of the THF, the resulting ion-selective membrane cov-
ered the underlying PEDOT film completely. The resulting ISEs were
conditioned in 0.01m N-methylpyridinium iodide for at least 24 h. Poten-
tiometric measurements were performed with a home-made multichannel
mV meter, using an Ag/AgCl (3m KCl) electrode as the reference elec-
trode. Activity coefficients were calculated by using the extended
Debye–Hꢄckel equation.[21] Selectivity coefficients were estimated by the
separate-solution method (SSM) employing 0.01m concentrations of dif-
ferent cations (chloride or iodide salts).[22] The measurements were con-
ducted at room temperature (23Æ28C). Selected ISEs were also studied
by using bupivacaine as the primary ion. Bupivacaine (1-butyl-N-[2,6-di-
methylphenyl]-2-piperidinecarboxamide) is an aromatic cation that is
used as a local anaesthetic and is commercially available (Sigma Chemi-
cal Co.) in the form of a hydrochloride salt. Two other local anaesthetics,
namely lidocaine (2-diethylamino-N-[2,6-dimethylphenyl]acetamide) and
procaine (p-aminobenzoic acid diethylaminoethyl ester), in the form of
their hydrochloride salts (Sigma Chemical Co.), were used for compari-
son purposes.
Tropylium tetrakis(4-phenoxyphenyl)borate (8·1): The complex was pre-
pared by mixing equimolar amounts of solutions of 8 and borate 1 in ace-
tonitrile. The crystalline complex formed immediately. 1H NMR
(200 MHz, CD3CN): d = 6.7–7.4 (m, 36H; borate), 9.2 ppm (s, 7H; tro-
pylium); ESI-MS: m/z: 869 [2·(8)+ÀB(-Ph-O-Ph)4]; exact mass: 869.3832
[M+2·8]+ (calcd for C62H50O4B, 869.3802).
Imidazolium tetrakis(4-phenoxyphenyl)borate (9·1): The cation was pre-
pared according to the literature procedure.[20] The complex was prepared
by mixing equimolar amounts of solutions of imidazolium perchlorate (9)
and borate
1
in acetonitrile (no precipitate). 1H NMR (200 MHz,
CD3CN): d = 6.7–7.4 (m, 36H; borate + 2H; imidazolium), 8.4 ppm (s,
1H; imidazolium); ESI-MS: m/z: 826 [2·(9)+ÀB(-Ph-O-Ph)4]; exact
mass: 825.3588 [M+2·9]+ (calcd. for C54H46O4N4B, 825.3612).
1-Methylimidazolium tetrakis(4-phenoxyphenyl)borate (10·1): The cation
was prepared according to the literature procedure.[20] The complex was
prepared by mixing equimolar amounts of solutions of 1-methylimidazoli-
um perchlorate (10) and borate 1 in acetonitrile (no precipitate). 1H
NMR (200 MHz, CD3CN): d = 3.8 (s, 3H; N-CH3), 6.7–7.3 (m, 36H;
borate), 8.3 ppm (s, 1H; 1-Me-imidazolium); ESI-MS: m/z: 854
[2·(10)+ÀB(-Ph-O-Ph)4]; exact mass: 853.3959 [M+2·10]+ (calcd for
C56H50O4N4B, 853.3925).
N-Methylpyridinium tetrakis(biphenyl)borate (6·2): The complex was
prepared by mixing equimolar amounts of solutions of N-methylpyridini-
um iodide (6) and borate 2 in acetonitrile. The solid complex formed im-
mediately upon mixing of the solutions. Crystals were grown from aceto-
1
nitrile by slow evaporation. H NMR (200 MHz, CD3CN + CD3OD): d
= 4.3 (s, 3H; N-CH3), 7.3–7.6 (m, 36H; borate), 8.0 (m, 2H; Me-pyridi-
nium), 8.5 (t, 1H; Me-pyridinium), 8.6 ppm (d, 2H; Me-pyridinium);
ESI-MS: m/z: 812 [2·(6)+ÀB(-Ph-Ph)4]; exact mass: 811.4194 [M+2·6]+
(calcd for C60H52N2B, 811.4224).
Stability constant determination by 1H NMR titration: A standard so-
lution of the guest in [D3]acetonitrile/[D4]methanol (1:1, v/v) was pre-
pared at a concentration of 2ꢃ10À3 m, just sufficient to give an observable
NMR signal. A series of donor solutions (0.01–1.0m) were prepared by
weighing out appropriate amounts of the donor. A 2-mL portion of the
standard solution was then added and the flask was re-weighed. The solu-
tions were thoroughly mixed and the spectrum was measured immediate-
ly; 5 mm NMR tubes sealed with Parafilm to avoid evaporation were
used. The temperature (303 K) was held constant during the measure-
ments. The stability constant Ka for the complexation was calculated
from NMR chemical shifts using the Benesi–Hildebrand least-squares
line-fitting procedure.[23]
1-Ethyl-4-(methoxycarbonyl)pyridinium tetrakis(biphenyl)borate (7·2):
The complex was prepared by mixing equimolar amounts of solutions of
7 and borate 2 in acetonitrile. The yellow solid complex formed immedi-
ately upon mixing of the solutions. 1H NMR (200 MHz, CD3CN): d =
1.6 (t, 3H; N-CH2CH3), 4.0 (s, 3H; OCH3), 4.6 (q, 2H; N-CH2CH3), 7.2–
7.7 (m, 36H; borate), 8.4 (m, 2H; arom. cation), 8.9 ppm (d, 2H; arom.
cation); ESI-MS: m/z: 956 [2·(7)+ÀB(-Ph-Ph)4]; exact mass: 955.4621
[M+2·7]+ (calcd for C66H60O4N2B, 955.4646).
Tropylium tetrakis(biphenyl)borate (8·2): The complex was prepared by
mixing equimolar amounts of solutions of tropylium tetrafluoroborate (8)
and borate 2 in acetonitrile (no precipitate). Black crystals formed within
a few hours. 1H NMR (200 MHz, CD3CN): d
= 6.9–7.9 (m, 38H;
2078
ꢂ 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2005, 11, 2071 – 2080